DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories Limited
02 4USV Private Limited
03 1Teva API India Limited
04 1Aurobindo Pharma Limited
05 1Biocon Limited
06 1Cipla Ltd.
07 1HETERO LABS LIMITED
08 1Hetero Labs Limited
09 1Juzen Chemical Corporation
10 1MSN Organics Private Limited
11 1MYLAN LABORATORIES LIMITED
12 1Synthimed Labs Private Limited
13 1Takeda Pharmaceutical Company LTD
01 2PIOGLITAZONE HYDROCHLORIDE
02 12Pioglitazone Hydrochloride
03 1Pioglitazone hydrochloride
04 1pioglitazone hydrochloride
01 12India
02 1Israel
03 2Japan
04 1U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-052
Start Marketing Date : 2012-06-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62147-0005
Start Marketing Date : 2010-02-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 15894-0017
Start Marketing Date : 2023-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62147-0070
Start Marketing Date : 2010-02-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62147-0071
Start Marketing Date : 2010-02-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62147-0020
Start Marketing Date : 2010-02-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7566
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59361-003
Start Marketing Date : 2003-03-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50379-0008
Start Marketing Date : 2012-07-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11532-5001
Start Marketing Date : 2011-05-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Actos manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Actos, including repackagers and relabelers. The FDA regulates Actos manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Actos API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Actos manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Actos supplier is an individual or a company that provides Actos active pharmaceutical ingredient (API) or Actos finished formulations upon request. The Actos suppliers may include Actos API manufacturers, exporters, distributors and traders.
click here to find a list of Actos suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Actos as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Actos API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Actos as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Actos and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Actos NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Actos suppliers with NDC on PharmaCompass.
We have 12 companies offering Actos
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?